gimli
KREBSBIO stock analysis context
KREBS BIOCHEMICALS & IND Stock Context for AI Screening
KREBS BIOCHEMICALS & IND is a small-cap stock in Healthcare. This page summarizes key screening signals for KREBS BIOCHEMICALS & IND, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive KREBSBIO stock pagePrice
₹63.90
1W return
-1.54%
1M return
+7.09%
3M return
+18.55%
6M return
-0.99%
1Y return
-15.63%
Market cap
₹137.77 cr
PE
-8.14
PB
-0.85
ROE
+12.76%
ROCE
-8.54%
RSI
57.66
Turnover
₹0.01 cr
Why it can matter in screens
- Momentum: KREBSBIO is above 50DMA; RSI is 57.66.
- Returns: 1D -1.53%, 1W -1.54%, 1M +7.09%, 3M +18.55%, 1Y -15.63%.
- Trend levels: 52W high ₹104.94, 52W low ₹39.75, off high -39.11%.
- Liquidity: latest turnover is ₹0.01 cr; volume vs 20D is +0.30%.
- Valuation/profitability: PE -8.14, PB -0.85, ROE +12.76%, ROCE -8.54%.
- Growth: 3Y sales CAGR -10.14%, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 6.81 cr | 1.14 cr | -2.34 cr | -1.09 |
| 2025-12-31 | 7.27 cr | 0.30 cr | -3.13 cr | -1.45 |
| 2025-09-30 | 4.17 cr | -2.79 cr | -6.14 cr | -2.85 |
| 2025-06-30 | 5.48 cr | -2.08 cr | -5.32 cr | -2.47 |
| 2025-03-31 | 6.10 cr | -5.07 cr | -8.27 cr | -3.83 |
| 2024-12-31 | 11.47 cr | -4.46 cr | -7.74 cr | -3.59 |
| 2024-09-30 | 12.86 cr | -2.62 cr | n/a | -2.67 |
| 2024-06-30 | 12.89 cr | -2.16 cr | -5.17 cr | -2.40 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 43.31 cr | -14.32 cr | -26.94 cr | -12.49 |
| 2024-03-31 | 50.42 cr | -8.27 cr | -19.73 cr | -9.15 |
| 2023-03-31 | 52.13 cr | -15.16 cr | -24.69 cr | -11.30 |
| 2022-03-31 | 59.70 cr | -32.85 cr | -44.53 cr | -20.81 |
| 2021-03-31 | n/a | n/a | n/a | nan |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 163.25 cr | 0.13 cr | 224.84 cr | -162.75 cr |
| 2025-12-31 | 165.91 cr | 0.15 cr | 221.47 cr | -160.83 cr |
| 2025-09-30 | 168.03 cr | 0.13 cr | 219.44 cr | -157.71 cr |
| 2025-03-31 | 169.04 cr | 0.02 cr | 212.21 cr | -146.24 cr |
| 2025-03-31 | 169.04 cr | 0.14 cr | 257.21 cr | -146.24 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | n/a | n/a | n/a |
| 2025-12-31 | n/a | n/a | n/a |
| 2025-09-30 | n/a | n/a | n/a |
| 2025-06-30 | n/a | n/a | n/a |
| 2025-03-31 | -7.89 cr | -11.45 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +72.74% | +0.50% | +0.00% | +0.00% | +26.76% | +0.00% |
| 2025-12-31 | +72.74% | +0.50% | +0.00% | +0.00% | +26.76% | +0.00% |
| 2025-09-30 | +72.74% | +0.50% | +0.00% | +0.00% | +26.76% | +0.00% |
| 2025-06-30 | +72.74% | +0.50% | +0.00% | +0.00% | +26.76% | +0.00% |
| 2025-03-31 | +72.74% | +0.50% | +0.00% | +0.00% | +26.76% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 429,121.06 cr | 40.824543 | +15.06% | +7.26% |
| DIVISLAB | DIVI S LABORATORIES LTD | 174,585.42 cr | 68.707369 | +17.81% | +0.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 147,849.87 cr | 68.354079 | +29.94% | +39.35% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 119,204.71 cr | 64.295958 | +23.21% | +21.70% |
| CIPLA | CIPLA LTD | 111,088.72 cr | 29.624450 | +12.91% | -6.65% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 108,331.15 cr | 21.874917 | +20.44% | +16.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 105,181.70 cr | 24.542479 | +13.88% | +1.20% |
| LUPIN | LUPIN LIMITED | 103,385.66 cr | 22.341869 | +29.22% | +15.72% |
Try these prompts
- Analyze KREBS BIOCHEMICALS & IND with valuation, momentum and industry peers
- Compare KREBSBIO with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare KREBSBIO with other Healthcare stocks
Data snapshot: 2026-06-03. Not investment advice.